MOZ/TIF2-induced acute myeloid leukaemia in transgenic fish

British Journal of Haematology
Julia ZhuravlevaLaurent Delva

Abstract

The inv(8)(p11q13) chromosomal abnormality, described in acute myeloid leukaemias (AML), fuses the histone acetyl-transferase (HAT) MYST3 (MOZ) gene with another HAT gene, NCOA2 (TIF2). We generated a transgenic zebrafish in which the MYST3/NCOA2 fusion gene was expressed under control of the spi1 promoter. An AML developed in 2 of 180 MYST3/NCOA2-EGFP-expressing embryos, 14 and 26 months after injection of the fusion gene in a one-cell embryo, respectively. This leukaemia was characterised by an extensive invasion of kidneys by myeloid blast cells. This model, which is the first zebrafish model of AML, demonstrates the oncogenic potency of MYST3/NCOA2 fusion gene.

References

Mar 21, 1998·British Journal of Haematology·S CoulthardD M Swirsky
Feb 8, 2003·Science·David M LangenauA Thomas Look
Nov 16, 2005·Annual Review of Genetics·Jill L O de Jong, Leonard I Zon
Oct 4, 2006·Proceedings of the National Academy of Sciences of the United States of America·Hatem E SabaawyDennis D Hickstein
Jan 26, 2007·Leukemia·J ChenJ D Griffin
Feb 26, 2008·Experimental Hematology·Julia ZhuravlevaLaurent Delva

❮ Previous
Next ❯

Citations

Apr 1, 2010·Disease Models & Mechanisms·Marina C Mione, Nikolaus S Trede
Jun 3, 2011·Endocrine-related Cancer·Caitlin Bourque, Yariv Houvras
Jan 14, 2011·Haematologica·Benoist PruvotEric Solary
May 21, 2014·Oncology Reports·Ioannis PanagopoulosSverre Heim
Aug 2, 2012·Advances in Hematology·A Michael ForresterElspeth M Payne
Jun 14, 2015·Current Opinion in Genetics & Development·Richard M White
Nov 20, 2015·Science China. Life Sciences·WeiXu MaWenQing Zhang
Oct 2, 2012·Journal of Genetics and Genomics = Yi Chuan Xue Bao·Jin XuZilong Wen
Jul 4, 2012·Leukemia Research·Kaisa J TeittinenOlli Lohi
Feb 9, 2016·Experimental Hematology·Anne LargeotGeorges Lacaud
May 27, 2009·British Journal of Haematology·Elspeth Payne, Thomas Look
Sep 2, 2009·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Anne K Voss, Tim Thomas
Aug 29, 2012·Acta Paediatrica·Olli LohiMika Rämet
Oct 8, 2015·Blood Reviews·Xiangguo ShiAnskar Y H Leung
Mar 25, 2014·Current Opinion in Genetics & Development·Jennifer YenDerek L Stemple
Aug 1, 2015·Future Medicinal Chemistry·Xiayang XieYong Teng
Jun 16, 2015·Frontiers in Oncology·Xiao-Jian SunLan Wang
Jun 13, 2015·BioMed Research International·Jeng-Wei LuLiang-In Lin
Apr 18, 2015·Journal of Hematology & Oncology·Parisa RasighaemiAlister C Ward
Apr 28, 2016·Leukemia·C TregnagoM Pigazzi
Jan 13, 2017·ELife·Inês M TenenteDavid M Langenau
Dec 4, 2012·Veterinary Pathology·H R Shive
Dec 20, 2017·Frontiers in Oncology·Kathryn S Potts, Teresa V Bowman
Aug 24, 2013·Nature Reviews. Cancer·Richard WhiteLeonard Zon
Apr 29, 2020·Oncotarget·Gilseung ParkJ Kimble Frazer
Oct 9, 2018·Frontiers in Cell and Developmental Biology·Jeremy T Baeten, Jill L O de Jong
Sep 15, 2019·Disease Models & Mechanisms·Martina KonantzClaudia Lengerke
May 28, 2020·Cells·William Tyler Frantz, Craig J Ceol
Aug 8, 2020·Cancers·Ludivine RabyPierre-Olivier Angrand
Jun 1, 2014·Current Pathobiology Reports·Barbara Squiban, J Kimble Frazer
Dec 20, 2020·Wiley Interdisciplinary Reviews. Developmental Biology·Brandon MolinaStephanie Grainger
Aug 31, 2019·Bulletin du cancer·Ludivine RabyPierre-Olivier Angrand

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.